Compare Summit Therapeutics Inc (SMMT) vs iShares TIPS Bond ETF (TIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs iShares TIPS Bond ETF — how do they compare? Summit Therapeutics Inc trades at $14.58 (market cap $10.48B), while iShares TIPS Bond ETF trades at $107.93. Which is the better fit depends on your goals.
| SMMT | TIP | |
|---|---|---|
Market Cap | $10.48B | — |
Sector | Health | Fixed Income |
52-Week High | $29.32 | $112.20 |
52-Week Low | $13.05 | $107.91 |
Enterprise Value | $9.90B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About iShares TIPS Bond ETF
TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →
